60,000 vials of innovative drugs against COVID-19 delivered to Ukraine

60,000 vials of innovative drugs against COVID-19 delivered to Ukraine

Ukrinform
Some 20,000 vials of Bamlanivimab and 40,000 vials of Etesevimab have been delivered to Ukraine, the Ukrainian Health Ministry has reported.

"The latest agreement on receiving this assistance was reached during Ukrainian President Volodymyr Zelensky's visit to the United States. Some 20,000 vials of Bamlanivimab and 40,000 vials of Etesevimab are already in Ukraine and have been shipped to the regions," Health Minister Viktor Liashko said.

The Health Ministry also updated the protocol "The provision of medical care for the treatment of coronavirus disease (COVID-19)," which provides for the use of drugs Bamlanivimab and Etesevimab.

Read also: COVID-19: Ukraine will move into yellow zone on Sep 23

This will help doctors battling with COVID-19 to have clear instructions on when and how to use these drugs properly, the ministry added.

According to the report, the drugs have a direct effect on the virus - the drugs bind to the spike proteins of the virus, preventing them from entering the cell, speeding up the recovery of patients with COVID-19 and preventing complications.

The drugs were delivered to Ukraine with the assistance of the Embassy of Ukraine in the United States as humanitarian aid provided by the U.S. charity organization Direct Relief.

Photo credit: Ukrainian Health Ministry

op


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website ukrinform.net not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website ukrinform.net and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2021 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period:
-